Platelet-active drugs: the relationships among dose, effectiveness, and side effects

Chest. 1998 Nov;114(5 Suppl):470S-488S. doi: 10.1378/chest.114.5_supplement.470s.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / therapeutic use
  • Dipyridamole / adverse effects
  • Dipyridamole / therapeutic use
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Ticlopidine / adverse effects
  • Ticlopidine / therapeutic use

Substances

  • Cyclooxygenase Inhibitors
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Dipyridamole
  • Ticlopidine
  • Aspirin